Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingfeng He

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Environmental Research and Public Health|December 1, 2020
Validation of the Simplified Chinese Version of the Brief Diabetes Quality of Life (DQoL) Questionnaire Based on a Cross-Sectional StudyZhijia Tang, Xinying Jiang, Lan Hong, et al.
Frontiers in Pharmacology|December 5, 2025
Cost-utility analysis of PCSK9 inhibitors for hypercholesterolemia: a Chinese healthcare perspectiveDandan Hu, Xu Deng, Mengwen Feng, et al.
Carbohydrate Polymers|November 16, 2016
Enhanced antibacterial and wound healing activities of microporous chitosan-Ag/ZnO composite dressingZhong Lu, Jingting Gao, Qingfeng He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2022
Covalent Binding Mechanism of Furmonertinib and Osimertinib With Human Serum AlbuminYali Wu, Lili Chen, Jian Chen, et al.
Frontiers in Pharmacology|December 12, 2022
Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERSZhen Feng, Xiaoye Li, Wai Kei Tong, et al.
Neural Computing & Applications|September 26, 2022
Machine learning techniques for CT imaging diagnosis of novel coronavirus pneumonia: a reviewJingjing Chen, Yixiao Li, Lingling Guo, et al.
Toxics|December 22, 2022
Applications of In Silico Models to Predict Drug-Induced Liver InjuryJiaying Lin, Min Li, Wenyao Mak, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An OverviewQiuyu Jia, Qingfeng He, Li Yao, et al.
Chemico-Biological Interactions|February 11, 2023
Evaluating the impact of co-administered drug and disease on ripretinib exposure: A physiologically-based pharmacokinetic modeling approachChunyang Pan, Yifan Cheng, Qingfeng He, et al.
Frontiers in Public Health|July 10, 2026
Beyond BMI: central obesity identifies overlooked fatty liver disease risk in adults with normal body mass index undergoing routine health examinationsQingfeng He, Shang Li, Qian He, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Environmental Research and Public Health|December 1, 2020
Validation of the Simplified Chinese Version of the Brief Diabetes Quality of Life (DQoL) Questionnaire Based on a Cross-Sectional StudyZhijia Tang, Xinying Jiang, Lan Hong, et al.
Frontiers in Pharmacology|December 5, 2025
Cost-utility analysis of PCSK9 inhibitors for hypercholesterolemia: a Chinese healthcare perspectiveDandan Hu, Xu Deng, Mengwen Feng, et al.
Carbohydrate Polymers|November 16, 2016
Enhanced antibacterial and wound healing activities of microporous chitosan-Ag/ZnO composite dressingZhong Lu, Jingting Gao, Qingfeng He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2022
Covalent Binding Mechanism of Furmonertinib and Osimertinib With Human Serum AlbuminYali Wu, Lili Chen, Jian Chen, et al.
Frontiers in Pharmacology|December 12, 2022
Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERSZhen Feng, Xiaoye Li, Wai Kei Tong, et al.
Neural Computing & Applications|September 26, 2022
Machine learning techniques for CT imaging diagnosis of novel coronavirus pneumonia: a reviewJingjing Chen, Yixiao Li, Lingling Guo, et al.
Toxics|December 22, 2022
Applications of In Silico Models to Predict Drug-Induced Liver InjuryJiaying Lin, Min Li, Wenyao Mak, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An OverviewQiuyu Jia, Qingfeng He, Li Yao, et al.
Chemico-Biological Interactions|February 11, 2023
Evaluating the impact of co-administered drug and disease on ripretinib exposure: A physiologically-based pharmacokinetic modeling approachChunyang Pan, Yifan Cheng, Qingfeng He, et al.
Frontiers in Public Health|July 10, 2026
Beyond BMI: central obesity identifies overlooked fatty liver disease risk in adults with normal body mass index undergoing routine health examinationsQingfeng He, Shang Li, Qian He, et al.
Pageof 7